Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia

Heart Lung Circ. 2020 Aug;29(8):1109-1111. doi: 10.1016/j.hlc.2020.06.008. Epub 2020 Jul 1.

Authors

Dona H Adikari¹, Virag V Kushwaha², Nigel S Jepson²

Affiliations

¹ Cardiology Department, Prince of Wales Hospital, Sydney, NSW, Australia. Electronic address: Dona.Adikari@health.nsw.gov.au.
² Cardiology Department, Prince of Wales Hospital, Sydney, NSW, Australia.

No abstract available

Keywords: Cardiovascular disease; Myocardial infarction.

Publication types

Editorial

MeSH terms

Australia / epidemiology
Betacoronavirus*
COVID-19
Cardiovascular Diseases / diagnosis
Cardiovascular Diseases / epidemiology*
Cardiovascular Diseases / therapy*
Communicable Disease Control / organization & administration*
Coronavirus Infections / epidemiology*
Coronavirus Infections / prevention & control
Coronavirus Infections / transmission
Humans
Pandemics / prevention & control
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / prevention & control
Pneumonia, Viral / transmission
SARS-CoV-2